Palavra-chave: CHRONIC MYELOID LEUKAEMIA

RESPONSE TO SECOND-LINE VACCINES CML GSTT1 NILOTINIB GENE RUNX1 POLYMORPHISMS EXON 6 ANGIOGENESIS INHIBITOR BCR-ABL SARS-COV-2 HOCT1 S-TRANSFERASE MU1 PHILADELPHIA CHROMOSOME-POSITIVE DASATINIB THETA1 IMATINIB CYTOGENETIC RESPONSES GSTM1 TYROSINE KINASE INHIBITORS GENERIC IMATINIB SECOND-GENERATION D-HPLC BCR-ABL1 PERIPHERAL-BLOOD